| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 44 |
| 1 | CINACALCET | 42 |
| 2 | CINACALCET HYDROCHLORIDE | 36 |
| 3 | ZOLEDRONIC ACID | 25 |
| 4 | CAPECITABINE | 16 |
| 5 | SORAFENIB | 16 |
| 6 | CISPLATIN | 15 |
| 7 | ETOPOSIDE | 15 |
| 8 | TEMOZOLOMIDE | 14 |
| 9 | INTERFERON BETA-1A | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SEVELAMER HYDROCHLORIDE | 1 | 0.0017 |
| 1 | PEMIGATINIB | 1 | 0.0012 |
| 2 | CINACALCET HYDROCHLORIDE | 36 | 0.0008 |
| 3 | SORAFENIB | 16 | 0.0008 |
| 4 | ETELCALCETIDE | 2 | 0.0007 |
| 5 | TEMOZOLOMIDE | 14 | 0.0007 |
| 6 | ZOLEDRONIC ACID | 25 | 0.0006 |
| 7 | LOMITAPIDE MESYLATE | 2 | 0.0005 |
| 8 | SALINE NASAL SPRAY | 2 | 0.0005 |
| 9 | PAMIDRONATE DISODIUM | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | RANK Ligand Inhibitor [EPC] | 44 |
| 1 | Kinase Inhibitor [EPC] | 18 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 16 |
| 3 | Platinum-based Drug [EPC] | 15 |
| 4 | Topoisomerase Inhibitor [EPC] | 15 |
| 5 | Alkylating Drug [EPC] | 14 |
| 6 | Interferon beta [EPC] | 9 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 8 |
| 8 | Corticosteroid [EPC] | 6 |
| 9 | Vitamin C [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 2 | 0.0005 |
| 1 | RANK Ligand Inhibitor [EPC] | 44 | 0.0002 |
| 2 | Topoisomerase Inhibitor [EPC] | 15 | 0.0002 |
| 3 | Vitamin D3 Analog [EPC] | 3 | 0.0001 |
| 4 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 16 | 0.0001 |
| 6 | Alkylating Drug [EPC] | 14 | 0.0001 |
| 7 | Platinum-based Drug [EPC] | 15 | 0.0001 |
| 8 | Interferon beta [EPC] | 9 | 0.0000 |
| 9 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |